CLSI GP47 (R2019)

Management of Critical- and Significant-Risk Results, 1st Edition, GP47Ed1E, GP47ESEd1E

Clinical and Laboratory Standards Institute, 12/01/2015

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/12/2015

Pages:112

File Size:2 files , 7.2 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides current best practice recommendations for developing and implementing a policy and procedures for the identification, reporting, and management of critical- and significant-risk laboratory results. Emphasis is placed on management responsibilities such as development of the policy, the process, procedures, job descriptions, and monitoring systems that ensure effective reporting and compliance with regulatory requirements.

Executive Summary
This is an executive summary of GP47–Management of Critical- and Significant-Risk Results. It provides a compilation of all key recommendations from GP47 for policies and processes as well as risk management principles and information technology for the management of laboratory results that indicate critical or significant risk to patients.

More CLSI standard pdf

CLSI GP41

CLSI GP41

Collection of Diagnostic Venous Blood Specimens, 7th Edition, GP41Ed7E

$90.00 $180.00

CLSI M58-ED1

CLSI M58-ED1

Methods for the Identification of Cultured Microorganisms Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, 1st Edition

$90.00 $180.00

CLSI GP48 (R2022)

CLSI GP48 (R2022)

Essential Elements of a Phlebotomy Training Program, 1st Edition, GP48Ed1E

$90.00 $180.00

CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

$90.00 $180.00